Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

NCT03330899 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

432

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza
H7N9 Influenza

Interventions

BIOLOGICAL: H7N9 antigen + adjuvant IB160
BIOLOGICAL: H7N9 antigen + adjuvant SE
BIOLOGICAL: H7N9 antigen without adjuvant
BIOLOGICAL: Placebo (PBS)

Sponsor

Butantan Institute